Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
By 1898, however, the business had outgrown its temporary quarters and moved into its own space in downtown Warsaw.
In 1901 he moved the operation to Niles, Michigan—taking with him his wife of five years, Winifred Stoner.
In 1901 he moved the operation to Niles, Michigan—taking with him his wife of five years, Winifred Stoner. It was in Michigan, in 1903, that he incorporated the company as DePuy Manufacturing Company of Elk-hart, Indiana.
Unfortunately, however, the move to Michigan did not accomplish what DePuy had hoped, so in 1904 he and Winifred moved the splint business back to Warsaw.
By 1919 the company had 16 employees, six of whom were traveling salesmen.
Over the next 15 years, DePuy grew out his team; by 1919, he had 16 employees in total, including Justin Zimmer.
In 1924 Winifred remarried, wedding H. Herschel Leiter, a local insurance salesman who had previously worked as a salesman for DePuy.
After 20 years of working with the DePuy company, John Zimmer branched out to begin his own business in 1926.
When Winifred DePuy Leiter died in 1949, her second husband was left as sole owner of DePuy Manufacturing.
Leiter's death in 1950 threw the company into a state of near-crisis, as Leiter had promised to leave control of the company to its salesmen but actually bequeathed it to his new wife instead.
Founded in 1960, Synthes is a medical device company based in Switzerland and Pennsylvania, the US, and focused on the largest maker of implants to mend bone fractures, for $20.2bn.
In 1963 Thackray began working with the world’s foremost pioneer in hip replacement surgery, Sir John Charnley, to produce cemented hip fixation systems.
They sold DePuy to a group of investors in 1965, and Landis became the company’s president.
DePuy changed ownership again in 1968, when Bio-Dynamics, Inc., a blood diagnostic business, acquired it.
In 1968, they sold the company to Indianapolis-based Bio-Dynamics, a blood diagnostic business.
In 1968 the company expanded into a whole new product line: hip replacements.
In 1974 Bio-Dynamics itself was purchased by Boehringer Mannheim, one of the largest pharmaceutical companies in Europe.
Fifty-one years later, in 1977, four men with orthopedic backgrounds formed another company called Biomet.
In 1979 the company gained the rights to use a new technology--a method of sintering a porous surface to orthopaedic implants, thereby allowing human tissue to be more effectively fixed--devised by Canadian Oxygen, Ltd.
In 1980 DePuy introduced its LCS Total Knee System, an artificial knee that used mobile (rather than fixed) bearings to duplicate more closely the mechanics of a healthy human knee.
During the 1980’s, DePuy’s AML® Hip System became the first cementless porous-coated implant indicated for biological fixation in the world.
With a presence already established in Canada and Latin America, the company in 1984 targeted the Italian market through a network of 12 regional importers.
James Lent, who had accrued considerable industry experience as the president of Johnson & Johnson's orthopaedic division, took over as company president in 1985 after Robert Williams's retirement.
He drove further expansion in its joint replacement business, as well as signing a partnership with DuPont in 1989 that brought environmental protection devices, including glove liners for healthcare workers, into DePuy Manufacturing’s portfolio. As a result, the company’s revenues reached $95m in 1985.
Some of this growth was the result of a strategic partnership established in 1989 with the DuPont Company.
Lent changed offices in 1990, becoming DePuy's chairman and chief executive officer.
The first of these came in 1990, when Boehringer Mannheim purchased Charles F. Thackray Limited, of Leeds, England.
In November of 1991, DePuy made Thackray its international headquarters and rechristened it DePuy International Ltd.
In 1991 DePuy purchased the Rotek Corporation, a medical products manufacturer in Albuquerque, New Mexico.
After it was acquired by DePuy, Rotek expanded rapidly, moving into a new 20,000-square-foot facility in 1992.
At the beginning of 1992, DePuy announced a new strategic alliance with Genentech, Inc., a San Francisco-based biotechnology company.
DePuy expanded its presence in the arthroscopy market in 1993, establishing a separate manufacturing operation in Ontario, California, to produce arthroscopy instruments.
In 1993 the company broke into the spinal products market in a joint venture with the German company Biedermann Motech.
Another 1994 acquisition was DePuy CMW, a bone cement manufacturer based in Blackpool, England.
DePuy Manufacturing also got involved in the trauma products market with the support of Boehringer Mannheim buying ACE Medical, a leader in this field, in 1994 and placing its management under DePuy Manufacturing’s control.
One Hundred Years of Orthopedic Excellence, Warsaw, Ind.: DePuy, Inc., 1995.
In October 1996, DePuy went public, offering 14 million shares of common stock priced at $17.50 per share.
In early 1997, the company purchased almost two million shares of Landanger-Camus, a leading French manufacturer of hip implants and one of the top distributors of orthopedic supplies and devices.
DePuy Inc., a Johnson & Johnson company since 1998, is a leading designer, manufacturer, and distributor of orthopaedic devices and supplies.
In 1998, Johnson & Johnson, one of the world’s largest healthcare companies, acquired DePuy, by then known as DePuy, Inc.
The company had diversified to the point that 50 percent of its sales in 1999 occurred outside the United States.
As of the beginning of 1999, DePuy Motech/AcroMed had received marketing clearance from the FDA for a new spinal device that was designed to facilitate spinal fusion—and further developments in the area of spinal implants were likely to follow.
At the same time, DePuy and J&J were also grappling with lawsuits surrounding failures of its Pinnacle hip implants, which were first FDA approved in 2000 and had a similar metal-on-metal design to the ASR products.
However, as early as 2006, the US Food and Drug Administration (FDA) received complaints about the ASR device.
“It wasn’t exactly an accident of history, but it was an evolution over time, as one company spun off from another,” says Brad Bishop, executive director of OrthoWorx, formed in 2009 and funded by a grant from the Eli Lilly company.
Synthes and its subsidiary Norian had previously plead guilty in 2009 to illegally selling a bone void filler for unapproved uses and failing to properly report deaths and adverse events related to the product.
The DePuy ASR (Articular Surface Replacement) Hip Resurfacing System and the ASR XL Acetabular System total hip replacement were recalled in August of 2010 by DePuy Orthopaedics and the company also discontinued the all-metal models of the Pinnacle hip devices.
Approved in 2011, DePuy’s ATTUNE knee system allows for a total knee replacement to allow for more natural movement.
Later, in 2012, Johnson & Johnson acquired global medical device company Synthes, Inc., and combined that company with the DePuy franchise to create one of the world’s largest orthopaedic and neurological businesses.
Thousands of ASR hip lawsuits were settled in 2013 for a total cost of $4 billion, and about 6,000 Pinnacle hip lawsuits were settled for about $1 billion.
Your dashboard for the Zimmer-Biomet merger | OrthoStreams July 4th, 2015 at 10:02 am […] Early history of 3 Orthopedics giants in the unlikely city of Warsaw Indiana (OrthoStreams) […]
The company includes approximately 250 subsidiaries with operations in over 60 countries and products sold in over 175 countries, with worldwide sales of $70.1 billion during 2015.
Johnson & Johnson’s business is divided into three major segments — Pharmaceuticals, Medical Devices and Consumer Products — whose respective percentages of 2015 total company revenues were 44.9%, 35.9%, and 19.3%.
In December 2016, DePuy Synthes announced it would acquire Pulsar Vascular Inc., adding Pulsar to its Codman division.
DePuy began seeing the first Attune Knee lawsuits in 2017 and more continue to be filed.
Warsaw: Indiana’s Lake City & The World’s Orthopedic Capital | OrangeBean Indiana October 4th, 2018 at 7:17 pm […] as well as local efforts to lure companies from the orthopedic industry to town, Warsaw’s history with orthopedic innovation goes back over a hundred […]
DePuy is the world’s oldest manufacturer of orthopedics devices and remains one of the largest, with estimated 2018 revenue of $8.8 billion, making the company, the second largest orthopedics manufacturer in the world.
In January 2021, DePuy Synthes announced it had received FDA clearance to use its VELYS robotic-assisted surgery product alongside its ATTUNE total knee system.
"DePuy, Inc. ." International Directory of Company Histories. . Retrieved June 21, 2022 from Encyclopedia.com: https://www.encyclopedia.com/books/politics-and-business-magazines/depuy-inc-0
Rate how well DePuy Orthopaedics Inc lives up to its initial vision.
Do you work at DePuy Orthopaedics Inc?
Is DePuy Orthopaedics Inc's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Lumenis | 1966 | $425.0M | 99 | 31 |
| Biolase | 1987 | $22.8M | 190 | - |
| Hillrom | 1915 | $3.0B | 10,000 | 130 |
| Wright Medical Technology | - | $920.9M | 1,180 | - |
| Scott Specialties | 1962 | $17.4M | 200 | - |
| Acumed | 1988 | $35.6M | 475 | - |
| Bisco Hatori | 1987 | $2.8M | 20 | 1 |
| Tosoh Bioscience - Separations & Purification | 1987 | $16.6M | 750 | - |
| Coloplast | 1978 | $2.1B | 500 | 85 |
| Medtronic Spine LLC | 1994 | $11.0M | 50 | - |
Zippia gives an in-depth look into the details of DePuy Orthopaedics Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about DePuy Orthopaedics Inc. The employee data is based on information from people who have self-reported their past or current employments at DePuy Orthopaedics Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by DePuy Orthopaedics Inc. The data presented on this page does not represent the view of DePuy Orthopaedics Inc and its employees or that of Zippia.
DePuy Orthopaedics Inc may also be known as or be related to DePuy Orthopaedics Inc.